From: Model-based evaluation of the impact of prophylactic vaccination applied to Ebola epidemics in Sierra Leone and Democratic Republic of Congo
Vaccine efficacy
Model based on Sierra Leone 2014 data
Model based on DRC 2018 (North Kivu) data
30%
90%
Non-HCW
HCW
H30
H90
G0
23%
56%
33%
71%
31%
66%
42%
79%
G5
70%
64%
77%
G10
74%
85%
80%
89%